List of Lung Disorders
WHO classified pulmonary hypertension into 5 groups including Pulmonary Arterial Hypertension, PH associated with left heart disease, PH associated with lung disease etc… read on to know the details.
Remodulin pump is approved by FDA. It is a small implantable pump comes used by patients for intravenous infusion therapy with Remodulin.
One feature that separates group II pulmonary hypertension from other is elevated pulmonary capillary wedge pressure i.e. greater than 15 mm Hg.
There is a small case of the report available on safety and efficacy of sildenafil. Treprostinil (subcutaneous) with sildenafil (oral) combination is the best option for chronic pulmonary hypertension patients instead of just using sildenafil.
A child with bronchitis will exhibit the usual signs of cold to include a runny nose, fever, chills, and a productive cough. In some cases, the cough may cause the child to vomit as well. During the initial stages, the cough may be dry but as the condition advances the cough becomes wet and is productive of greenish tinged sputum.
In majority of the cases, the symptoms of bronchiolitis last for a maximum of two weeks after which the symptoms start to fade away. However, children with severe or advanced cases of bronchiolitis have cough and wheezing for up to three to four weeks post treatment.
Sildenafil (Revatio), tadalafil (Adcirca), Orenitram, inhaled (Tyvaso), IV (Remodulin) are the newer medicines available for pulmonary hypertension.
The drug of choice for pulmonary hypertension depends on the group of PH and the underlying cause of it. PH is a progressive disease, which is life threatening if not treated has a survival rate of only 3 years.
Pulmonary hypertension treatment guidelines include proper diagnosis of the patient and classifying the disease according to WHO classification and treatment. PAH should be differentiated with other pulmonary hypertension and right heart catheterization should be performed for confirmation.
The prognosis of pulmonary hypertension is not good; if it is left untreated the victim dies within 3 years of diagnosis. If the sufferer is in low risk group then he can live for over ten years. The death of pulmonary hypertension patient occurs due to right ventricular failure in most cases.
Rheumatoid arthritis and SLE, connective tissue diseases, liver diseases, congenital heart diseases, sickle cell anemia, HIV infection can cause secondary pulmonary hypertension.